Work

Crenolanib, a Type I FLT3 TKI, Can be Safely Combined with Cytarabine and Anthracycline Induction Chemotherapy and Results in High Response Rates in Patients with Newly Diagnosed FLT3 Mutant Acute Myeloid Leukemia (AML)

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.1071.1071

Authors: Eunice S. Wang, Richard M. Stone, Martin S. Tallman, Roland B. Walter, John R. Eckardt, Robert Collins

Institutions: Roswell Park Comprehensive Cancer Center, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Fred Hutch Cancer Center, Arog Pharmaceuticals (United States), The University of Texas Southwestern Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2736138252

FWCI: 7.122

Cites:

Cited by: 53

Related to: 10